---
$id: https://graph.org.ai/products/commodity/51141553
$type: Product
source: UNSPSC
code: "51141553"
title: "Denzimol"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Denzimol

**UNSPSC Code**: 51141553
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C19H20N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9C78O7JATH, chemically known as 1h-imidazole-1-ethanol, alpha-(4-(2-phenylethyl)phenyl)- but generally known as denzimol, which bears US NIH Compound Identifier 53626. European Medicines Agency schedules Denzimol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06980MIG. The term DENZIMOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). DENZIMOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule denzimol under HS 29332990 and SITC 51573. As of Q4 2014, DENZIMOL remains the US FDA Preferred Term for this commodity. Denzimol bears US NLM identifiers UMLS ID C0057398 and NCI Concept Code C78001. SMILES: OC(C1CCC(CCC2CCCCC2)CC1)CN1CCNC1.

